NCT06239194
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06239194
Title Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors ModeX Therapeutics, An OPKO Health Company
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Sarah Cannon Research Institute RECRUITING Denver Colorado 80218 United States Details
Sylvester Comprehensive Cancer Center - University of Miami Health System RECRUITING Miami Florida 33136 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
Sarah Cannon Research Institute RECRUITING Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
NEXT Oncology RECRUITING San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field